Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.

Oliveras A, de la Sierra A.

J Hum Hypertens. 2014 Apr;28(4):213-7. doi: 10.1038/jhh.2013.77. Epub 2013 Aug 29. Review.

PMID:
23985879
2.

Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.

Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC; Hygia Project Investigators.

Chronobiol Int. 2013 Mar;30(1-2):207-20. doi: 10.3109/07420528.2012.701135. Epub 2012 Oct 19.

PMID:
23077975
3.

Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension.

Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF.

Blood Press Monit. 2003 Oct;8(5):181-5.

PMID:
14624166
4.

Resistant hypertension: a practical clinical approach.

Muxfeldt ES, de Souza F, Salles GF.

J Hum Hypertens. 2013 Nov;27(11):657-62. doi: 10.1038/jhh.2013.34. Epub 2013 May 2. Review.

PMID:
23636008
5.

[Importance of standardized stepwise screening in patients with resistant hypertension].

Prkačin I, Balenovic D, Cavrić G, Bartolek D, Bulum T.

Acta Med Croatica. 2014 Apr;68(2):111-5. Croatian.

PMID:
26012147
6.

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.

Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C, Carra R, Chiandussi L.

Clin Exp Hypertens. 2001 Apr;23(3):203-11.

PMID:
11339687
7.

True resistant hypertension: is it possible to be recognized in the office?

Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF.

Am J Hypertens. 2005 Dec;18(12 Pt 1):1534-40.

PMID:
16364821
8.

Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM.

Hypertension. 2011 May;57(5):898-902. doi: 10.1161/HYPERTENSIONAHA.110.168948. Epub 2011 Mar 28.

9.

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.

Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, Facchetti R, Redon J, Mancia G, Grassi G.

J Hypertens. 2013 Oct;31(10):2018-24. doi: 10.1097/HJH.0b013e328363823f.

PMID:
23838657
10.

Is resistant hypertension really resistant?

Brown MA, Buddle ML, Martin A.

Am J Hypertens. 2001 Dec;14(12):1263-9.

PMID:
11775136
11.

Prevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetes.

Yokoyama H, Araki S, Watanabe S, Honjo J, Okizaki S, Yamada D, Shudo R, Shimizu H, Sone H, Haneda M.

Diabetes Res Clin Pract. 2015 Oct;110(1):18-25. doi: 10.1016/j.diabres.2015.08.007. Epub 2015 Aug 29.

PMID:
26361860
13.

Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.

Hernández-delRey R, Armario P, Martin-Baranera M, Sánchez P, Cárdenas G, Pardell H.

Blood Press Monit. 1998;3(6):331-7.

PMID:
10212374
14.

Urinary albumin excretion is associated with true resistant hypertension.

Oliveras A, Armario P, Hernández-Del Rey R, Arroyo JA, Poch E, Larrousse M, Roca-Cusachs A, de la Sierra A.

J Hum Hypertens. 2010 Jan;24(1):27-33. doi: 10.1038/jhh.2009.35.

PMID:
19421225
15.

[Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension].

Hernández del Rey R, Armario P, Martín-Baranera M, Castellanos P.

Med Clin (Barc). 2006 Jul 15;127(7):241-5. Spanish.

PMID:
16942725
16.

Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Lazaridis AA, Sarafidis PA, Ruilope LM.

Curr Hypertens Rep. 2015 Oct;17(10):78. doi: 10.1007/s11906-015-0590-9. Review.

PMID:
26277726
17.

Treatment of resistant hypertension.

Czarina Acelajado M, Calhoun DA.

Minerva Cardioangiol. 2009 Dec;57(6):787-812. Review.

PMID:
19942848
18.

Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.

Barochiner J, Alfie J, Aparicio LS, Cuffaro PE, Rada MA, Morales MS, Galarza CR, Waisman GD.

Clin Exp Hypertens. 2013;35(6):412-7. doi: 10.3109/10641963.2012.739236. Epub 2012 Nov 13.

PMID:
23148480
19.

2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.

International Society for Chronobiology; American Association of Medical Chronobiology and Chronotherapeutics; Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk; Spanish Society of Atherosclerosis; Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F.

Chronobiol Int. 2013 Apr;30(3):355-410. doi: 10.3109/07420528.2013.750490.

PMID:
23517220
20.

White-coat resistant hypertension.

Mezzetti A, Pierdomenico SD, Costantini F, Romano F, Bucci A, Di Gioacchino M, Cuccurullo F.

Am J Hypertens. 1997 Nov;10(11):1302-7.

PMID:
9397251

Supplemental Content

Support Center